Package Leaflet: Information for the User
Levitra 10 mg Film-Coated Tablets
vardenafil
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack and other information
Levitra contains vardenafil, which belongs to a group of medicines called phosphodiesterase 5 inhibitors, used to treat erectile dysfunction in adult men, a condition which means that the man cannot achieve or maintain an erection.
At least one in ten men has, at some time, problems achieving or maintaining an erection. This may be due to physical or psychological causes, or a combination of both. Regardless of the cause, muscle and blood vessel changes can lead to insufficient blood in the penis to achieve and maintain an erection.
Levitra will only work when you are sexually stimulated. This medicine reduces the action of a natural chemical in your body that makes it difficult to maintain an erection.
Do not take Levitra
Warnings and precautions
Consult your doctor or pharmacist before taking Levitra.
Be cautious when taking Levitra
Children and adolescents
Levitra should not be used in children and adolescents under 18 years of age.
Other medicines and Levitra
Tell your doctor or pharmacist if you are using, have recently used, or might use any other medicines, including those obtained without a prescription.
Some medicines may cause problems, especially:
Do not use Levitra film-coated tablets in combination with any other medicine for the treatment of erectile dysfunction, including Levitra orodispersible tablets.
Taking Levitra with food, drinks, and alcohol
You can take Levitra with or without food, but it is best to avoid taking it after a large or high-fat meal, as this may delay its effect.
Pregnancy and breastfeeding
Levitra should not be used in women.
Driving and using machines
In some people, Levitra may cause dizziness or affect vision. Do not drive or operate machinery if you feel dizzy or have problems with your vision after taking Levitra.
Follow the instructions for administration of this medicine exactly as prescribed by your doctor.
In case of doubt, consult your doctor or pharmacist again. The recommended dose is 10 mg.
Take a Levitra tablet 25-60 minutes before sexual activity. With sexual stimulation, you may achieve an erection from 25 minutes up to 4-5 hours after taking Levitra.
Do not take Levitra film-coated tabletswith any other formulation of Levitra.
Do not take Levitramore than once a day.
If you feel that the effect of Levitra is too strong or too weak, inform your doctor. He or she may suggest changing to another formulation of Levitra with a different dose, depending on your response to the medicine.
If you take more Levitra than you should
Taking too many Levitra tablets may cause more side effects and lead to a severe backache. If you have taken more Levitra than you should, consult your doctor.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them. Most of the side effects are mild or moderate.
Some patients have experienced a sudden loss of vision in one or both eyes. Stop taking Levitra and contact your doctor immediately.
There have also been reports of sudden loss of hearing.
There have been reports of sudden death, fast or irregular heartbeats, heart attacks, chest pain, and stroke (including temporary reduction of blood flow to parts of the brain and bleeding in the brain), in men taking vardenafil. Most of these men had pre-existing heart problems. It is not possible to determine whether these events were directly related to vardenafil.
The likelihood of experiencing a side effect is described in the following categories:
Very common side effects:
may affect more than 1 in 10 people
Common side effects:
may affect up to 1 in 10 people
Uncommon side effects:
may affect up to 1 in 100 people
Rare side effects:
may affect up to 1 in 1,000 people
Very rare or unknown side effects:
may affect less than 1 in 10,000 people or the frequency cannot be estimated from the available data
Reporting of side effects
If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Appendix V. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton after "EXP". The expiry date refers to the last day of the month.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.
Composition of Levitra
In the tablet core: crospovidone, magnesium stearate, microcrystalline cellulose, anhydrous colloidal silica.
In the film coating: macrogol 400, hypromellose, titanium dioxide (E171), yellow iron oxide (E172), red iron oxide (E172).
Appearance of the product and packaging
Levitra 10 mg film-coated tablets are orange, with the Bayer cross on one side and the strength (10) on the other. Each pack contains 2, 4, 8, 12, or 20 tablets. Not all pack sizes may be marketed.
Marketing authorization holder and manufacturer
Marketing authorization holder
Bayer AG
51368 Leverkusen
Germany
Manufacturer
Bayer AG
Kaiser-Wilhelm-Allee
51368 Leverkusen
Germany
For further information, please contact your local representative of the marketing authorization holder.
België/Belgique/Belgien | Lietuva |
Bayer SA-NV | UAB Bayer |
Tél/Tel: +32-(0)2-535 63 11 | Tel: +370 523 36 868 |
???????? | Luxembourg/Luxemburg |
????? ???????? ???? | Bayer SA-NV |
T??.: +359-(0)2-424 72 80 | Tél/Tel: +32-(0)2-535 63 11 |
Ceská republika | Magyarország |
Bayer s.r.o. | Bayer Hungária KFT |
Tel: +420 266 101 111 | Tel.: +36 14 87-4100 |
Danmark | Malta |
Bayer A/S | Alfred Gera and Sons Ltd. |
Tlf: +45 45 23 50 00 | Tel: +35 621 44 62 05 |
Deutschland | Nederland |
Jenapharm GmbH & Co. KG | Bayer B.V. |
Tel: +49 (0)3641-87 97 444 | Tel: +31-(0)297-28 06 66 |
Eesti | Norge |
Bayer OÜ | Bayer AS |
Tel: +372 655 85 65 | Tlf: +47-23 13 05 00 |
Ελλ?δα | Österreich |
Bayer Ελλ?ς ΑΒΕΕ | Bayer Austria Ges. m. b. H. |
Τηλ: +30 210 61 87 500 | Tel: +43-(0)1-711 46-0 |
España | Polska |
Bayer Hispania S.L. | Bayer Sp. z o.o. |
Tel: +34-93-495 65 00 | Tel.: +48 22 572 35 00 |
France | Portugal |
Bayer HealthCare | Bayer Portugal, Lda. |
Tél (N° vert) : +33-(0)800 87 54 54 | Tel: +351 21 416 42 00 |
Hrvatska | România |
Bayer d.o.o. | SC Bayer SRL. |
Tel: + 385-(0)1-6599 900 | Tel: +40-21-529 59 00 |
Ireland | Slovenija |
Bayer Limited | Bayer d. o. o. |
Tel: +353 1 216 3300 | Tel: +386 (0)1 58 14 400 |
Ísland | Slovenská republika |
Icepharma hf. | Bayer, spol. s r.o. |
Sími: +354-540 8000 | Tel: +421 2-59 21 31 11 |
Italia | Suomi/Finland |
Bayer S.p.A. | Bayer Oy |
Tel: +39 02 397 81 | Puh/Tel: +358-20 785 21 |
Κ?προς | Sverige |
NOVAGEM Limited | Bayer AB |
Τηλ: +357 22 48 38 58 | Tel: +46 (0)8 580 223 00 |
Latvija | United Kingdom |
SIA Bayer | Bayer plc |
Tel: +371 67 845 563 | Tel: +44 (0) 118 206 3000 |
Date of last revision of this leaflet {month, year} Other sources of information
Detailed information on this medicine is available on the European Medicines Agency web site: http://www.ema.europa.eu